One center’s experience with OKT3 in renal transplantation: patient and graft survival, complications, and cost analysis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2000-05, Vol.32 (3), p.572-573
Hauptverfasser:	Güz, G, Emiroğlu, R, Demirhan, B, Köseoğlu, F, Karakayalı, H, Bilgin, N
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Creatinine - blood Drug Costs Drug Resistance Female Graft Rejection - drug therapy Graft Survival Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - economics Immunosuppressive Agents - therapeutic use Kidney Transplantation Male Middle Aged Muromonab-CD3 - adverse effects Muromonab-CD3 - economics Muromonab-CD3 - therapeutic use Postoperative Complications Retreatment Steroids - therapeutic use Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!